MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Preferred place of death (PPOD) in PD, PSP and MSA

    C. Morris, R. Walker, M. Lee, J. Adamson (Newcastle, United Kingdom)

    Objective: To ascertain whether people with PD, PSP and MSA have a PPOD Background: Achieving a PPOD is felt to be an important factor in…
  • 2019 International Congress

    PARKINSON DISEASE HAMPERS PARTICIPATION IN THE CIVIC RESPONSIBILITY OF VOTING: a study of barriers to expression of a fundamental human right

    O. Oguntunde, O. Ojo, O. Agabi, M. Rizig, N. Okubadejo (Lagos, Nigeria)

    Objective: To determine the impact of PD on the participation of persons with Parkinson disease in the recently concluded national elections in Lagos,Nigeria, and explore…
  • 2019 International Congress

    [18F] FDG-PET findings associated with cognitive impairment if multiple system atrophy

    KW. Park, NR. Choi, SY. Jo, SJ. Kim, YJ. Park, SJ. Chung, CS. Lee (Seoul, Republic of Korea)

    Objective: To explore the cortical metabolic pattern associated with cognitive impairment in multiple system atrophy (MSA). Background: Cognitive impairment (CI) has been increasingly recognized in…
  • 2019 International Congress

    Dyskinesia Rates in Patients with Parkinson’s Disease on CVT-301 (levodopa inhalation powder)

    E. Pourcher, A. Corbin, J. Qian, C. Kenney (Quebec City, QC, Canada)

    Objective: Analysis of dyskinesia as reported by PD diary, adverse events, UPDRS part IV dyskinesia score and examiner rated observation, during a phase 3 study…
  • 2019 International Congress

    Prevalence and predisposing factors of Parkinson disease: A barangay community-based study in Quezon, Philippines

    MC. Rosales, DJ. Robles, RCN. Rodriguez, NB. Romana, JM. Rosales, G. Salazar, R. Rosales (Manila, Philippines)

    Objective: The researchers aim to determine the prevalence of the Parkinson Disease in a locale and explore the possible predisposing factors on the development of…
  • 2019 International Congress

    Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): An Update on Recruitment

    R. Schneider, L. Omberg, T. Myers, S. Anthwal, E. Kayson, C. Tarolli, M. Daeschler, E. Macklin, E. Dorsey, L. Mangravite, M. Schwarzschild, T. Simuni (Chicago, IL, USA)

    Objective: To leverage technology to develop a new model for the long-term follow-up of Parkinson’s disease (PD) clinical trial cohorts and investigate novel disease measures.…
  • 2019 International Congress

    Is safinamide helpful in multiple system atrophy?

    R. Simões, A. Gonçalves, JJ. Ferreira (Lisboa, Portugal)

    Objective: To retrospectively review the clinical benefit of safinamide in patients with Multiple System Atrophy. Background: Safinamide is a new monoamine oxidase-B inhibitor, with dopaminergic…
  • 2019 International Congress

    Quantifying eye and gait abnormalities in Parkinson’s patients after Deep brain stimulation

    Z. Su, M. Brzezick, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To examine the usefulness of precise measurements of gait and eye movements as a means of quantifying PD. The aim is to identify and…
  • 2019 International Congress

    Using Quantitative Susceptibility Mapping to Predict Dementia in Parkinson’s Disease

    G. Thomas, L. Leyland, J. Acosta-Cabronero, R. Weil (London, United Kingdom)

    Objective: To investigate how brain iron deposition relates to visual function and dementia risk in Parkinson’s Disease (PD). Background: Oxidative stress due to brain iron…
  • 2019 International Congress

    Amylin single-nucleotide polymorphism and Parkinson’s disease

    R. Valenti-Azcarate, I. Martinez-Valbuena, I. Marcilla Garcia, G. Marti, M. Carmona-Abellan, MT. Tuñon-Alvarez, MT. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this study was to evaluate if a single nucleotide polymorphism (SNP) in the amylin sequence is present in patients with Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 195
  • 196
  • 197
  • 198
  • 199
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley